Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Johnson & Johnson Vision, formerly known as AMO Japan, is a global leader in the ophthalmic healthcare industry, providing innovative solutions for vision correction and eye health. The company's surgical division specializes in advanced technologies for cataract surgery, including the TECNIS family of intraocular lenses and the Catalys femtosecond laser system. It also offers comprehensive products for refractive surgery and the treatment of ocular surface diseases like dry eye. Originally established as a spin-off from Allergan and later operating as Abbott Medical Optics, the company was acquired by Johnson & Johnson in 2017. In Japan, the company maintains a strong presence, delivering high-quality medical devices and vision care products to clinics and hospitals nationwide. Its portfolio is designed to enhance surgical precision and improve long-term visual outcomes for patients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AMO Japan.